Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 3 | 2023 | 1267 | 0.780 |
Why?
|
| Heart Arrest | 1 | 2023 | 265 | 0.710 |
Why?
|
| Uvula | 1 | 2018 | 6 | 0.660 |
Why?
|
| Fiber Optic Technology | 1 | 2018 | 35 | 0.650 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 455 | 0.610 |
Why?
|
| Physicians | 1 | 2023 | 673 | 0.530 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 429 | 0.520 |
Why?
|
| Research Design | 2 | 2018 | 594 | 0.520 |
Why?
|
| Positive-Pressure Respiration | 2 | 2019 | 41 | 0.500 |
Why?
|
| Intraoperative Care | 2 | 2019 | 82 | 0.480 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 864 | 0.470 |
Why?
|
| Biomedical Research | 1 | 2018 | 375 | 0.470 |
Why?
|
| Surgical Procedures, Operative | 2 | 2019 | 182 | 0.430 |
Why?
|
| Lung Diseases | 2 | 2019 | 263 | 0.420 |
Why?
|
| Obesity | 2 | 2019 | 963 | 0.310 |
Why?
|
| Fatty Acids | 1 | 2023 | 130 | 0.230 |
Why?
|
| Dysbiosis | 1 | 2023 | 70 | 0.220 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2022 | 9 | 0.220 |
Why?
|
| Antigens, Neoplasm | 2 | 2005 | 325 | 0.220 |
Why?
|
| Anesthesia, General | 2 | 2019 | 114 | 0.220 |
Why?
|
| Feces | 1 | 2023 | 319 | 0.210 |
Why?
|
| Mast-Cell Sarcoma | 1 | 2000 | 15 | 0.200 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2011 | 559 | 0.180 |
Why?
|
| Postoperative Complications | 1 | 2019 | 2207 | 0.170 |
Why?
|
| Trans-Activators | 1 | 2000 | 429 | 0.160 |
Why?
|
| Fluid Therapy | 1 | 2018 | 50 | 0.150 |
Why?
|
| Lung Injury | 1 | 2018 | 47 | 0.150 |
Why?
|
| Intubation, Intratracheal | 1 | 2018 | 144 | 0.150 |
Why?
|
| Heart Transplantation | 1 | 2022 | 705 | 0.140 |
Why?
|
| Perioperative Care | 1 | 2018 | 161 | 0.140 |
Why?
|
| Respiration, Artificial | 1 | 2018 | 334 | 0.130 |
Why?
|
| Kidney Transplantation | 1 | 2022 | 849 | 0.130 |
Why?
|
| Humans | 11 | 2023 | 86601 | 0.130 |
Why?
|
| Graft Rejection | 1 | 2000 | 1065 | 0.130 |
Why?
|
| Lymphocyte Subsets | 1 | 2011 | 64 | 0.100 |
Why?
|
| Body Mass Index | 2 | 2019 | 770 | 0.100 |
Why?
|
| Lung | 1 | 2017 | 1170 | 0.100 |
Why?
|
| Interferon Type I | 1 | 2011 | 175 | 0.100 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2011 | 104 | 0.090 |
Why?
|
| Pulmonary Atelectasis | 1 | 2019 | 18 | 0.090 |
Why?
|
| Tidal Volume | 1 | 2019 | 53 | 0.090 |
Why?
|
| Pleural Diseases | 1 | 2019 | 13 | 0.090 |
Why?
|
| Coronary Artery Bypass | 1 | 2011 | 228 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2011 | 425 | 0.080 |
Why?
|
| Neoplasms, Experimental | 2 | 2006 | 269 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 375 | 0.080 |
Why?
|
| Respiratory Insufficiency | 1 | 2019 | 150 | 0.080 |
Why?
|
| Melanoma | 1 | 2011 | 454 | 0.080 |
Why?
|
| STAT1 Transcription Factor | 2 | 2011 | 52 | 0.070 |
Why?
|
| Lymphopenia | 1 | 2006 | 28 | 0.070 |
Why?
|
| Clonal Anergy | 1 | 2006 | 30 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 71 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2011 | 1924 | 0.060 |
Why?
|
| Homeostasis | 1 | 2006 | 409 | 0.060 |
Why?
|
| Neoplasm Transplantation | 2 | 2005 | 391 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2006 | 337 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2019 | 7988 | 0.050 |
Why?
|
| Leukemia L1210 | 1 | 2000 | 12 | 0.050 |
Why?
|
| STAT6 Transcription Factor | 1 | 2000 | 28 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2000 | 148 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2011 | 3241 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1578 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2000 | 213 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2000 | 108 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2022 | 456 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 1195 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2000 | 315 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 1041 | 0.040 |
Why?
|
| Transfection | 1 | 2000 | 896 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2000 | 444 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2000 | 272 | 0.040 |
Why?
|
| Mice | 4 | 2011 | 11352 | 0.040 |
Why?
|
| Echocardiography | 1 | 2022 | 911 | 0.040 |
Why?
|
| Protective Factors | 1 | 2017 | 22 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2017 | 156 | 0.040 |
Why?
|
| Liver | 1 | 2022 | 1229 | 0.040 |
Why?
|
| Adoptive Transfer | 2 | 2006 | 168 | 0.030 |
Why?
|
| Animals | 5 | 2011 | 26581 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 1208 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2000 | 1458 | 0.030 |
Why?
|
| Female | 3 | 2019 | 44507 | 0.030 |
Why?
|
| Adult | 2 | 2019 | 25640 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 2426 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2006 | 1540 | 0.030 |
Why?
|
| Male | 2 | 2019 | 40956 | 0.030 |
Why?
|
| Neoplasms | 1 | 2006 | 2897 | 0.030 |
Why?
|
| Middle Aged | 1 | 2019 | 25017 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 481 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 826 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 8475 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 5209 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2011 | 409 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2011 | 530 | 0.020 |
Why?
|
| Genes, RAG-1 | 1 | 2006 | 13 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 5416 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 376 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 3092 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2005 | 100 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2006 | 679 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2006 | 372 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2005 | 209 | 0.010 |
Why?
|
| Pregnancy | 1 | 2011 | 2893 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 989 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 776 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 1056 | 0.010 |
Why?
|